DNAtrix, Inc.

One Greenway Plaza
Suite 930
Houston, TX 77046
713.715.6820 office
713.715.6820 fax

Website
www.dnatrix.com

DNAtrix is a biotech company commercializing an oncolytic virus therapy for glioblastoma, an aggressive form of brain cancer, with founders from the University of Texas M.D. Anderson Cancer Center and the University of California San Francisco Cancer Center. DNAtrix began its human clinical trials in early 2009.